Shares of IXICO plc (LON:IXI – Get Free Report) passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 11.51 and traded as low as GBX 8.82. IXICO shares last traded at GBX 8.82, with a volume of 11,405 shares.
IXICO Stock Down 5.9%
The firm has a market cap of £7.74 million, a price-to-earnings ratio of -4.51, a PEG ratio of -0.38 and a beta of 0.86. The business has a fifty day simple moving average of GBX 10.98 and a 200 day simple moving average of GBX 11.51. The company has a debt-to-equity ratio of 3.32, a current ratio of 2.85 and a quick ratio of 4.90.
IXICO (LON:IXI – Get Free Report) last posted its quarterly earnings data on Tuesday, December 9th. The company reported GBX (1.85) EPS for the quarter. IXICO had a negative net margin of 31.10% and a negative return on equity of 19.14%. As a group, equities analysts forecast that IXICO plc will post -289.3584879 EPS for the current fiscal year.
IXICO Company Profile
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
See Also
- Five stocks we like better than IXICO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
- This $15 Stock Could Go Down as the #1 Stock of 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
